Tresiba

Tresiba

Novo Nordisk

Tresiba (insulin degludec injection) is a long-acting insulin used to manage blood glucose in adults and children 1 year of age and older with diabetes. Tresiba is delivered via vial and syringe or pen. It is also available in U-100 and U-200 concentrations.


Features


Specs

Insulin Type:
Long-acting
Generic Name:
Insulin degludec
Delivery:
Syringe (U-100 only) or pen (U-100 and U-200)
Form:
Analog
Concentrations:
U-100 and U-200
Onset:
1 hour
Peak:
No peak
Duration:
At least 42 hours